1.41
price down icon4.08%   -0.06
after-market Handel nachbörslich: 1.40 -0.01 -0.71%
loading
Schlusskurs vom Vortag:
$1.47
Offen:
$1.5
24-Stunden-Volumen:
72,055
Relative Volume:
0.37
Marktkapitalisierung:
$119.84M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.65M
KGV:
-4.2457
EPS:
-0.3321
Netto-Cashflow:
$-15.84M
1W Leistung:
+13.71%
1M Leistung:
+21.55%
6M Leistung:
+7.63%
1J Leistung:
-29.50%
1-Tages-Spanne:
Value
$1.40
$1.50
1-Wochen-Bereich:
Value
$1.24
$1.50
52-Wochen-Spanne:
Value
$0.7709
$2.63

Cardiol Therapeutics Inc Stock (CRDL) Company Profile

Name
Firmenname
Cardiol Therapeutics Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
CRDL's Discussions on Twitter

Vergleichen Sie CRDL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CRDL
Cardiol Therapeutics Inc
1.41 119.84M 0 -21.65M -15.84M -0.3321
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
17.40 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.17 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.38 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.10 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.76 20.17B 16.54B -1.64B 749.00M -1.45

Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Eingeleitet H.C. Wainwright Buy
2025-01-28 Eingeleitet Rodman & Renshaw Buy
2024-06-26 Eingeleitet ROTH MKM Buy
2024-04-22 Eingeleitet H.C. Wainwright Buy

Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten

pulisher
Jun 18, 2025

(CRDL) Technical Patterns and Signals (CRDL:CA) - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 15, 2025

(CRDL) Investment Analysis (CRDL:CA) - news.stocktradersdaily.com

Jun 15, 2025
pulisher
Jun 13, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Up 2.1% – Here’s What Happened - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

(CRDL) Stock Market Analysis (CRDL:CA) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 05, 2025

Analysts Issue Forecasts for CRDL Q2 Earnings - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

All Eyes On ARCHER: Will Cardiol's Drug For Heart Muscle Inflammation Hit The Mark? - RTTNews

Jun 05, 2025
pulisher
Jun 04, 2025

(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

Cetera Investment Advisers Takes $56,000 Position in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Cardiol Therapeutics (NASDAQ:CRDL) Now Covered by Analysts at HC Wainwright - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

HC Wainwright & Co. Initiates Coverage of Cardiol Therapeutics (CRDL) with Buy Recommendation - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Cardiol Therapeutics (CRDL): HC Wainwright & Co. Initiates Coverage with a Buy Rating and $9 Price Target | CRDL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

H.C. Wainwright Initiates Coverage on Cardiol Therapeutics (CRDL) With Positive Outlook | CRDL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

(CRDL) Strategic Investment Guide (CRDL:CA) - news.stocktradersdaily.com

Jun 02, 2025
pulisher
Jun 01, 2025

RAD Reports Positive Preclinical Lu177-B7H3-mAb Data - Investing News Network

Jun 01, 2025
pulisher
May 29, 2025

Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise - SECFilings.com

May 29, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Announces AGM Results and New Board Member - TipRanks

May 29, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders | CRDL Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders - Newsfile

May 29, 2025
pulisher
May 29, 2025

Ex-Eli Lilly Chief Medical Officer Strengthens Cardiol Board as Critical Phase III Trial Nears Completion - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Cardiol Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 28, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting o - GuruFocus

May 27, 2025
pulisher
May 27, 2025

(CRDL) Market Insights and Trading Signals (CRDL:CA) - news.stocktradersdaily.com

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Inc. - Baystreet.ca

May 27, 2025
pulisher
May 27, 2025

Stocks In Play: Cardiol Therapeutics Inc. - Barchart.com

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast AGM Amidst Ongoing Clinical Trials - TipRanks

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT - Newsfile

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics Announces Virtual AGM: How Shareholders Can Participate Online May 28 - Stock Titan

May 27, 2025
pulisher
May 27, 2025

Cardiol Therapeutics (OTCMKTS:CRTPF) Stock Price Up 2.8% – Here’s Why - Defense World

May 27, 2025
pulisher
May 24, 2025

(CRDL) Investment Performance Report (CRDL:CA) - news.stocktradersdaily.com

May 24, 2025
pulisher
May 22, 2025

AMD Will Be as ‘Aggressive as Possible’ to Challenge Nvidia - The Globe and Mail

May 22, 2025
pulisher
May 22, 2025

Cardiol Therapeutics (TSE:CRDL) Stock Price Down 5.2% – Time to Sell? - Defense World

May 22, 2025
pulisher
May 14, 2025

(CRDL) Market Performance Analysis (CRDL:CA) - news.stocktradersdaily.com

May 14, 2025
pulisher
May 11, 2025

(CRDL) Strategic Equity Report (CRDL:CA) - news.stocktradersdaily.com

May 11, 2025
pulisher
May 11, 2025

Acceleration of RAD204 Phase 1 dose escalation trial - Investing News Network

May 11, 2025
pulisher
May 08, 2025

(CRDL) Advanced Trading Insights (CRDL:CA) - news.stocktradersdaily.com

May 08, 2025
pulisher
May 08, 2025

Cardiol Therapeutics Inc. (NASDAQ:CRDL) Given Consensus Rating of “Buy” by Analysts - Defense World

May 08, 2025
pulisher
May 06, 2025

Envestnet Asset Management Inc. Makes New Investment in Cardiol Therapeutics Inc. (NASDAQ:CRDL) - Defense World

May 06, 2025
pulisher
May 05, 2025

Lodgement of CONNEQT Pulse Device with the TGA - Investing News Network

May 05, 2025
pulisher
May 03, 2025

(CRDL) Trading Performance and Risk Management (CRDL:CA) - news.stocktradersdaily.com

May 03, 2025
pulisher
Apr 30, 2025

(CRDL) Daily Stock Insights (CRDL:CA) - news.stocktradersdaily.com

Apr 30, 2025
pulisher
Apr 30, 2025

March Quarterly Activities Report - Investing News Network

Apr 30, 2025
pulisher
Apr 30, 2025

March Quarterly Appendix 4C - Investing News Network

Apr 30, 2025
pulisher
Apr 30, 2025

Cardiol Therapeutics (TSE:CRDL) Trading Up 6.7% – What’s Next? - Defense World

Apr 30, 2025
pulisher
Apr 29, 2025

Profound Medical Corp. - Baystreet.ca

Apr 29, 2025
pulisher
Apr 29, 2025

Stocks in play: Cardiol Therapeutics Inc. - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors | CRDL Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Board Amid Phase III Trial Progress - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

The S&P 500 Is Doing Something That Hasn't Been Seen in Nearly 100 Years. Here Are the 10 Most Important Stocks to Keep an Eye On. - The Globe and Mail

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors - Newsfile

Apr 29, 2025
pulisher
Apr 29, 2025

Cardiol Therapeutics nominates ex-Eli Lilly CMO to board By Investing.com - Investing.com Canada

Apr 29, 2025

Finanzdaten der Cardiol Therapeutics Inc-Aktie (CRDL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$14.29
price down icon 0.07%
$9.01
price down icon 1.21%
$125.42
price down icon 1.02%
$284.27
price up icon 0.06%
drug_manufacturers_specialty_generic RDY
$15.07
price down icon 1.70%
$16.76
price up icon 1.21%
Kapitalisierung:     |  Volumen (24h):